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a b s t r a c t
Type I interferons (IFNs-α/β) play a key role for the antiviral state of host, and the porcine arterivirus;
porcine reproductive and respiratory syndrome virus (PRRSV), has been shown to down-regulate the
production of IFNs during infection. Non-structural protein (nsp) 1 of PRRSV has been identiﬁed as a viral
IFN antagonist, and the nsp1α subunit of nsp1 has been shown to degrade the CREB-binding protein
(CBP) and to inhibit the formation of enhanceosome thus resulting in the suppression of IFN production.
The study was expanded to other member viruses in the family Arteriviridae: equine arteritis virus
(EAV), murine lactate dehydrogenase-elevating virus (LDV), and simian hemorrhagic fever virus (SHFV).
While PRRSV–nsp1 and LDV–nsp1 were auto-cleaved to produce the nsp1α and nsp1β subunits, EAV–
nsp1 remained uncleaved. SHFV–nsp1 was initially predicted to be cleaved to generate three subunits
(nsp1α, nsp1β, and nsp1γ), but only two subunits were generated as SHFV–nsp1αβ and SHFV–nsp1γ.
The papain-like cysteine protease (PLP) 1α motif in nsp1α remained inactive for SHFV, and only the
PLP1β motif of nsp1β was functional to generate SHFV–nsp1γ subunit. All subunits of arterivirus nsp1
were localized in the both nucleus and cytoplasm, but PRRSV–nsp1β, LDV–nsp1β, EAV–nsp1, and SHFV–
nsp1γ were predominantly found in the nucleus. All subunits of arterivirus nsp1 contained the IFN
suppressive activity and inhibited both interferon regulatory factor 3 (IRF3) and NF-κB mediated IFN
promoter activities. Similar to PRRSV–nsp1α, CBP degradation was evident in cells expressing LDV–
nsp1α and SHFV–nsp1γ, but no such degradation was observed for EAV–nsp1. Regardless of CBP
degradation, all subunits of arterivirus nsp1 suppressed the IFN-sensitive response element (ISRE)-
promoter activities. Our data show that the nsp1-mediated IFN modulation is a common strategy for all
arteriviruses but their mechanism of action may differ from each other.
& 2014 Elsevier Inc. All rights reserved.
Introduction
The family Arterividae in the order Nidovirales consists of a
group of enveloped, single-stranded, positive-sense RNA viruses
including porcine reproductive and respiratory syndrome virus
(PRRSV), lactate dehydrogenase-elevating virus (LDV) of mice,
equine arteritis virus (EAV), and simian hemorrhagic fever virus
(SHFV). The arterivirus genome varies between 12.7 and 15.7 kb in
length but their genome organization is relatively consistent with
some minor variations (Snijder et al., 2013). At least 10 functional
open reading frames (ORFs) have been identiﬁed in the PRRSV
genome: ORF1a, ORF1b, ORF2a, ORF2b, and ORFs 3 through 7, plus
recently identiﬁed ORF5a within ORF5 (Firth et al., 2011; Johnson
et al., 2011; Meulenberg et al., 1993; Snijder et al., 1999; Wootton
et al., 2000). For SHFV, four additional ORFs (2a, 2b, 3, and 4)
immediately downstream of the replicase gene are duplicated
(Godeny et al., 1998), and the gene duplication was conﬁrmed in
four (krc1, krc2, krtg1, krtg2) newly identiﬁed SHFV isolates (Lauck
et al., 2011, 2013). In addition, a -2 ribosomal frame-shifting has
been reported for expression of transframe (TF) ORF in the nsp2-
coding region, and TF ORF is conserved in PRRSV, LDV and SHFV
(Fang et al., 2012). The structural proteins encoded by ORFs 2a
through 7 are expressed from the 30-co-terminal nested set of
subgenomic (sg) mRNAs (Firth et al., 2011; Godeny et al., 1998;
Johnson et al., 2011; Meulenberg et al., 1993; Snijder et al., 1999).
Mediated by the -1 frame-shifting in the ORF1a/ORF1b overlap-
ping region, two polyproteins pp1a and pp1ab are synthesized
(den Boon et al., 1991), and these polyproteins are proteolytically
processed by two papain-like cysteine proteinases (PLPs) 1α and
1β in nsp1, a papain-like proteinase (PLP2) in nsp2, and a serine
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protease (SP) in nsp4. Thus, the proteolytic processing of pp1a and
pp1ab generates 13 nsps for EAV and 14 nsps for PRRSV and LDV
(reviewed by Fang and Snijder, 2010; Snijder et al., 2013).
Arterivirus nsp1 is a multifunctional regulatory protein. For EAV,
nsp1 is thought to regulate the accumulation of the viral genomic
RNA and subgenomic (sg) mRNAs in a manner by determining the
levels at which their negative-stranded templates are produced
(Nedialkova et al., 2010). The N-terminal zinc ﬁnger (ZF) domain
was essential for this function (Tijms et al., 2001). Arterivirus nsp1
harbors several important motifs: two motifs of PLP1α and PLP1β,
two zinc ﬁnger motifs of ZF1 and ZF2, and a nuclease domain (Xue
et al., 2010; reviewed in Fang and Snijder, 2010; Snijder et al., 2013).
The PLP1α and PLP1β sequence motifs are relatively well con-
served among nsp1 of arteriviruses with some functional varia-
tions. Both PLP1α and PLP1β motifs are found in nsp1 of PRRSV,
LDV and EAV, but for EAV, PLP1α is inactive whereas PLP1β remains
functional (den Boon et al., 1995; Ziebuhr et al., 2000). The PLP1α
activity directs the internal cleavage of nsp1 to produce nsp1α, and
the PLP1β activity is thought to release nsp1β from nsp2 of pp1a
and pp1ab. In PRRSV, failure of the PLP1α-mediated nsp1 cleavage
impairs the synthesis of viral mRNA but does not affect the genome
replication. In contrast, no evidence of viral RNA synthesis was
detected in PLP1β-impaired PRRSV mutants, indicating that the
correct cleavage of nsp1β from nsp2 is essential for PRRSV genome
replication (Kroese et al., 2008). Interestingly, the protease activ-
ities of PRRSV nsp1α and PRRSV nsp1β become inactive once
cleaved due to the stable cohesion between the C-terminal exten-
sions (CTE) and PLP1 motifs according to the X-ray crystallographic
studies (Sun et al., 2009; Xue et al., 2010). The functional existence
of ZF1 at the N-terminal region of nsp1 has been conﬁrmed for
EAV, and the presence of ZF2 in the C-terminal region of nsp1α has
been described for PRRSV (Sun et al., 2009; Tijms et al., 2001). For
SHFV, the nsp1 sequence reveals an array of three potential
domains for PLP1α, PLP1β, and PLP1γ (Snijder et al., 2013), but
these motifs have not experimentally been conﬁrmed for their
function.
Restricted tropism of arteriviruses limits their host range to
suids, mice, equids, and non-human primates for PRRSV, LDV, EAV,
and SHFV, respectively, and macrophages appear to be the primary
target cells for their infections (Snijder and Meulenberg, 1998).
Arteriviruses establish persistent infection in certain circum-
stances, and LDV in particular causes a life-long persistence in
infected mice (Anderson et al., 1995; Plagemann et al., 1995).
Arteriviruses seem to have evolved to escape the host immune
surveillance and suppress the antiviral response. The type I
interferon (IFN) system is a key component of the innate immunity
and represents the ﬁrst lines of defense against virus infection
(Samuel, 2001). Subsequently, antiviral actions from IFN-
stimulated gene (ISG) expression contribute to the antiviral state
of cells (Sadler and Williams, 2008). For PRRSV however, IFN
production is negligible in virus-infected cells and pigs, and the
virus seems to suppress the IFN cascade (Albina et al., 1998). The
molecular basis for IFN suppression by PRRSV has recently been
explored and at least ﬁve viral proteins has been identiﬁed as an
IFN antagonist, which includes four non-structural proteins
(nsp1α, nsp1β, nsp2, and nsp11) and a structural protein (nucleo-
capsid, N) (Reviewed in Sun et al., 2012; Yoo et al., 2010).
Extensive studies have accentuated nsp1α and nsp1β as IFN
modulators for PRRSV, and the inhibition of both IFN production
and JAK-STAT (Janus Kinase-Signal Transducers and Activators of
Transcription) signaling pathways have been shown in virus-
infected cells and gene-transfected cells (Yoo et al., 2010; Sun et
al., 2012). Both IRF3-mediated and NF-κB-mediated IFN produc-
tion pathways are affected by nsp1α and nsp1β (Beura et al., 2010;
Chen et al., 2010; Song et al., 2010), and the functional domains
have been identiﬁed (Beura et al., 2012; Han et al., 2013; Li et al.,
2013). It was reported that PRRSV nsp1α reduced the NF-κB
activity (Song et al., 2010), and also nsp1α degrades the cyclic
AMP responsive element binding (CREB)-binding protein (CBP) in
a proteasome-dependent manner, leading to the suppression of
IFN production (Han et al., 2013). In contrast, PRRSV nsp1β
degrades karyopherin-α1 (KPNA1) and blocks nuclear transloca-
tion of interferon-stimulated gene factor 3 (ISGF3) (Patel et al.,
2010; Wang et al., 2013). Besides PRRSV, no such study has been
conducted for other member viruses in the family Arteriviridae. In
the current study, we have investigated the biogenesis of nsp1 of
arteriviruses and the role of nsp1 cleavage products for IFN
synthesis and suppression. We report that the IFN modulation
by nsp1 is a common strategy in arteriviruses for immune
modulation. The molecular bases of immune evasion however
may differ among arteriviruses.
Results
PLP domains in SHFV–nsp1
Two separate PLP domains, PLP1α and PLP1β, have been
identiﬁed in nsp1 of PRRSV. These domains consist of catalytic
residues C76 and H146, and C270 and H339, respectively. Both
PLP1α and PLP1β domains are functional and generate nsp1α and
nsp1β, respectively (Sun et al., 2009; Xue et al., 2010). For LDV, PLP
domains in nsp1 resemble those of nsp1 of PRRSV, and their
activities and cleavages may likely mimic those of PRRSV–nsp1. For
EAV, PLP1α is composed of K73 and H122, and the K–H motif
instead of the C–H motif in PRRSV has been shown to be inactive.
As a result, EAV–nsp1α is not cleaved off from EAV–nsp1β, and
thus uncleaved nsp1 is produced by the PLP1β activity (den Boon
et al., 1995; Snijder et al., 1992). For SHFV, three potential PLP
domains (PLP1α, PLP1β, and PLP1γ) are found according to
sequence comparisons and each domain is presumed to be
functional to generate nsp1α, nsp1β, and nsp1γ, respectively
(Fig. 1A). The SHFV–PLP1α domain consists of C115 and H130,
and resembles PRRSV–PLP1α and LDV–PLP1α. SHFV–PLP1β how-
ever is rather similar to SHFV–PLP1γ, suggesting gene duplication.
Both SHFV–PLP1β and SHFV–PLP1γ are aligned well with PRRSV–
PLP1β, LDV–PLP1β, and EAV–PLP1β (Fig. 1B).
To examine the cleavage products of nsp1 for each arterivirus,
nsp1 genes were individually cloned and expressed in cells
(Fig. 1D). A FLAG-tag was added to the N-terminus of each
construct and thus only N-terminal cleavage product would be
detected when using anti-FLAG antibody. LDV–nsp1α was identi-
ﬁed as a 22 kD protein (lane 2), and the molecular size was slightly
larger than 21 kD of PRRSV–nsp1α (lane 1), reﬂecting the pre-
dicted molecular weights of 21.1 kD and 20.8 kD for LDV–nsp1α
and PRRSV–nsp1α, respectively. EAV–nsp1 was detected as a
30 kD protein (lane 3). In cells expressing SHFV–nsp1, a 39 kD
protein was observed (Fig. 1D, lane 4), which was much larger than
the predicted size of 21 kD for SHFV–nsp1α and was rather similar
to the sum of nsp1α and nsp1β. This result suggests that the
SHFV–PLP1α domain may be non-functional and instead SHFV–
PLP1β cleaves off SHFV–nsp1β to generate a single protein of
nsp1α and nsp1β.
To conﬁrm the proteolytic activity of each PLP of SHFV–nsp1,
different sets of nsp1 constructs were made using a FLAG tag at
the N-terminus of each construct (Fig. 2A, left panel). Then, either
single or double amino acid mutations were introduced to the
catalytic sites to subvert the function of respective PLP. PRRSV–
nsp1 and PRRSV–nsp1α were included as a cleavage control. To
determine the enzymatic activity of SHFV–PLP1α, individual con-
structs were transfected to cells for 24 h and their cleavage
patterns were examined using anti-FLAG antibody. To exclude
M. Han et al. / Virology 458-459 (2014) 136–150 137
a possible inﬂuence by the N-terminal tag on the PLP1α activity,
a C-terminal-tagged construct was made and designated SHFV–
nsp1αβ/F. The nsp1αAA/β mutant was made to destroy the PLP1α
motif by substituting C115 and H130 to C115A and H130A,
respectively. After transfection, cell lysates were prepared and
subjected to Western blot using FLAG antibody. SHFV–nsp1α and
SHFV–nsp1β were expressed as 21 kD and 18 kD proteins, respec-
tively (Fig. 2A, right panel, lanes 4, 5). Expressions of SHFV–nsp1,
SHFV–nsp1αβ, SHFV–nsp1αβ/F, and SHFV–nsp1αAA/β produced a
39 kD protein which was the sum of nsp1α and nsp1β (lanes 6, 7,
8, 9), demonstrating that the cleavage did not occur between
nsp1α and nsp1β, and suggesting that SHFV–PLP1α was most
likely inactive.
To study the role of PLP1β, SHFV–nsp1β/γ and three additional
PLP1β mutants (nsp1βAH/γ, nsp1βCA/γ, and nsp1βAA/γ) were
constructed (Fig. 2B, left panel). When they were expressed
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Fig. 1. Schematic presentation and sequence alignments of arterivirus nsp1. (A) Structures and potential cleavage sites of nsp1 of PRRSV, LDV, EAV, and SHFV. The nsp1
protein for PRRSV, LDV, EAV, and SHFV is of 383, 381, 260, and 479 amino acids (aa), respectively. The catalytic residues for PLPs are indicated. Solid vertical arrows represent
the PLP-mediated cleavage sites and dotted arrows indicate predicted cleavage sites. Crossing-outs indicate non-functional PLPs. Numbers indicate amino acid positions
in nsp1. The space between aa positions 115 and 130 in SHFV–nsp1 indicates a deletion within the PLP1α domain in arteriviruses. (B) Multiple sequence alignments of the
PLP domains of nsp1 of arteriviruses. Conserved residues are shown in colors. PLP catalytic sites are boxed and indicated with asterisks. Dotted and solid lines indicate
amino acid deletions. Numbers in parenthesis indicate the numbers of amino acids between the two sequences. (C) Sequence alignments of PLP-directed cleavage sites
in nsp1 of different arteriviruses. Conserved amino acid residues are indicated in asterisks. Vertical arrows indicate cleavage sites. Sequence alignments were constructed
using Clustal X2.1 and presented in reference to the previous report (van Hemert and Snijder, 2007). (D) Identiﬁcation of the N-terminal cleavage product of individual
arterivirus nsp1. Individual nsp1 genes were FLAG-tagged at their N-terminus and transiently expressed in cells followed by SDS-PAGE and Western blot using anti-FLAG
antibody.
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in cells, an 18 kD protein was identiﬁed in SHFV–nsp1β/γ expres-
sing cells (Fig. 2B, right panel, lane 6), and it resembled
the predicted size of SHFV–nsp1β (Fig. 2B, right panel, lane 4),
indicating that PLP1β was enzymatically functional to release
SHFV–nsp1β from SHFV–nsp1. In contrast, a 33 kD protein was
identiﬁed in PLP1β mutants expressing cells, and this size was
consistent with the predicted size of the sum of nsp1β and nsp1γ
(Fig. 2B, right panel, lanes 7–9). The 10 kD protein in lane 5 is an
N-terminal cleavage product of SHFV–nsp1γ. This ﬁnding shows
that the PLP1β activity was responsible for the generation of
SHFV–nsp1β. Taken altogether, our data showed that SHFV–
PLP1α was non-functional and thus SHFV–nsp1 was cleaved by
PLP1β in between nsp1αβ and nsp1γ, and so only two cleavage
products were generated from SHFV–nsp1. We designated the N-
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Fig. 2. PLP-mediated cleavages of SHFV–nsp1. (A) Structural illustration and self-cleavage of SHFV–nsp1 mutants and PLP1α mutants. Each construct was fused with a
FLAG tag (dark areas) at the N-terminus or C-terminus. C and H residues of the catalytic dyad of PLP1α and alanine substitution are indicated (left panel). HeLa cells were
transfected with indicated constructs for 24 h, and cell lysates were subjected to Western blot using anti-FLAG antibody. 21 kD, 18 kD, and 31 kD proteins represent SHFV–
nsp1α, SHFV–nsp1β, and SHFV–nsp1α/β constructs, respectively (right panel). (B) Identiﬁcation of SHFV–PLP1β mediated cleavage products. Schematic diagrams for
constructs to determine PLP1β-mediated cleavages were shown in the left panel. 33 kD, 18 kD, and 15 kD proteins represent an uncleaved form of SHFV–nsp1β/γ, SHFV–
nsp1β, and SHFV–nsp1γ, respectively (right panel). (C) Generation of PLP1γ-mediated nsp1γ. Structural presentations of nsp1γ constructs were shown (left panel). nsp1γ was
extended to include a partial sequence of nsp2. 15 kD protein represents nsp1γ and 23 kD protein represent an uncleaved form of nsp1γ/2 P (right panel).
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terminal cleavage product of nsp1 as SHFV–nsp1αβ for the
following studies.
To study the role of SHFV–PLP1γ for the nsp1↓nsp2 cleavage,
the nsp1γ gene was fused with the 50 partial sequence of nsp2,
which was then named SHFV–nsp1γ/2P. Three mutants of PLP1γ
(nsp1γAH/2P, nsp1γCA/2P, and nsp1γAA/2P) were constructed to
destroy the potential PLP1γ activity by replacing catalytic amino
acids (Fig. 2C, left panel). A 15 kD band was identiﬁed in SHFV–
nsp1γ expressing and SHFV–nsp1γ/2P expressing cells (Fig. 2C,
right panel, lanes 4, 5). In contrast, in PLP1γ mutants expressing
cells, a 23 kD protein was identiﬁed (Fig. 2C, right panel, lanes 6–
8). This size was the sum of nsp1γ and the 50 terminal partial
sequence of nsp2. These results indicate that the SHFV–PLP1γ
domain was functional and cleaved the sequence between
nsp1↓nsp2 for the generation of nsp1γ.
PLP-speciﬁc cleavages of SHFV–nsp1
Since PLP1α was functional for PRRSV and LDV but non-
functional for EAV and SHFV, sequence speciﬁcity of the nsp1α–
nspβ cleavage sites were examined for PRRSV and LDV (Fig. 1C,
upper panel). CPFxxAxAT(N)V was identiﬁed as a consensus
sequence, in which x for any amino acids. Since the PRRSV–
PLP1α-mediated nsp1 cleavage occurs at M180↓A181, the cleavage
site for LDV–PLP1α was predicted to R181↓A182 which is an
immediate upstream of the second ‘A’ (Sun et al., 2009). Pre-
viously, the nsp1↓nsp2 cleavage sites were determined to
G260↓G261 for EAV and G383↓A384 for PRRSV (Snijder et al.,
1992; Xue et al., 2010). Both the SHFV–PLP1β and SHFV–PLP1γ
sequences were aligned well with the PLP1β sequence of PRRSV,
LDV, and EAV (Fig. 1B), and thus based on the sequence simila-
rities, the cleavages sites by SHFV–PLP1β and SHFV–PLP1γ were
relatively easily predictable. A consensus sequence of H(R/K)K(T)Y
(W)Y(F)G was identiﬁed at the C-terminal region of PRRSV–nsp1β,
LDV–nsp1β, and SHFV–nsp1αβ (Fig. 1C, lower panel), and because
the PRRSV–PLP1β cleavage occurs immediately after G383, the
LDV–PLP1β and SHFV–PLP1β cleavage sites were predicted to
G381↓Y382 and G350↓G351, respectively. For SHFV–PLP1γ, the
C-terminal four amino acid residues of SHFV–nsp1γ were highly
conserved with the arterivirus consensus sequence, and thus the
cleavage site by PLP1γ was predicted to G480↓R481 (Fig. 1C). To
conﬁrm the cleavage by SHFV–PLP1β and SHFV–PLP1γ, mutations
were introduced to substitute G350, G351, Y479, G480, and R481
to either serine (S) or valine (V) (Fig. 3A and B, left panels). Y479
served as a functionally silent control. Cleavage of the mutant
constructs was then analyzed by expressing each construct in cells
followed by Western blot using anti-FLAG antibody. Compared to
PLP1β cleavage of nsp1β/γ (Fig. 3A, right panel, lane 3), mutants
nsp1βAA/γ, G350S, G350V, and G351V (Fig. 3A, right panel, lanes,
4–7) were less effective for cleaving nsp1 whereas G351S as a
silent control efﬁciently released nsp1γ as anticipated (Fig. 3B,
right panel, lane 8). These ﬁndings support the cleavage of
G350↓G351 by PLP1β. To further determine the PLP1γ cleavage,
the mutants Y479S, Y479V, G480S, G480V, R481S, and R481V were
made and examined. No cleavage was found for Y479S, G480S, and
G480V (Fig. 3B, right lane 5, 7 and 8), and the size of the uncleaved
protein was identical to the size of nsp1γAA/2P (Fig. 3B, right
panel, lane 4). A full cleavage of SHFV–nsp1γ/2P was observed for
Y479V (Fig. 3B, right panel, lane 6) suggesting Y to V substitution
at position 479 did not block the cleavage by PLP1γ. The SHFV–
nsp1γ subunit was normally produced by any substitution of R481,
R481S, and R481V (Fig. 3B, right panel, lanes 9 and 10), supporting
the cleavage site by PLP1γ as Y479↓G480. The extra band above
nsp1γ became visible when exposure time was extended, and this
band also appeared in PRRSV–nsp1α, LDV–nsp1α, and SHFV–
nsp1γAA/2P (Fig. 3B). The nature of this band was unclear.
Cellular localization of arterivirus nsp1 individual subunits
PRRSV–nsp1α is a nuclear–cytoplasmic protein distributed
in the both nucleus and cytoplasm, whereas PRRSV–nsp1β and
EAV–nsp1 are predominantly found in the nuclear and perinuclear
regions (Li et al., 2012; Chen et al., 2010; Song et al., 2010; Tijms et
al., 2002). Thus, it was of interest to determine the cellular
distribution of each subunit of LDV–nsp1 and SHFV–nsp1. Plas-
mids coding for individual subunits of nsp1 were transfected into
MARC-145 or HeLa cells for 24 h, and the subcellular distribution
of each nsp subunit was determined by staining with anti-FLAG
antibody (Table 3). LDV–nsp1α was localized in the both nucleus
and cytoplasm (Fig. 4A, panel G), and its distribution patterns were
similar to those of PRRSV–nsp1α (Fig. 4A, panel A). A predominant
nuclear distribution was observed for LDV–nsp1β, SHFV–nsp1αβ,
and SHFV–nsp1γ (Fig. 4A, panels M, P, S). For SHFV–nsp1αβ in
particular, three staining patterns were observed: perinuclear
staining (Fig.4B, A-type), nuclear aggregation (Fig.4B, B-type),
and predominantly nuclear staining (Fig.4B, C-type). In HeLa cells,
74% of cells showed A-type staining and 10% of cells appeared to
be of C-type (Fig. 4C, upper panel, black bars). In MARC-145 cells,
the A-type staining pattern decreased to 54% while B-type staining
increased to 38% and C-type to be 8% (Fig. 4C, upper). For SHFV–
nsp1γ, a majority of cells (74%) showed A-type staining in HeLa
cells (Fig. 4C, lower), whereas in MARC-145 cells, three patterns
were relatively evenly distributed by 30% each, suggesting a
possible variation of their roles depending on cell types.
Suppression of IFN production by nsp1 subunits of arteriviruses
Both PRRSV–nsp1α and PRRSV–nsp1β have been reported to
participate in the suppression of IFN production, and thus it was of
interest to determine whether nsp1 of other arteriviruses plays a
similar role to antagonize the IFN activity. To examine this
possibility, a luciferase reporter assay was employed. Plasmids
coding for individual subunits of different arterivirus nsp1 were
individually co-transfected with the reporter plasmids, followed
by poly(I:C) stimulation for IFN induction. Virtually all subunits
exhibited comparable levels of IFN responses to those of PRRSV–
nsp1α and PRRSV–nsp1β (Fig. 5A, left panel). Similar to IFNβ–Luc,
every subunit of arterivirus nsp1 showed the suppression of IRF3–
Luc activity (Fig. 5A, middle panel) and NF-κB–Luc activity (Fig. 5A,
right panel). To further conﬁrm the suppression of IFN by nsp1, an
IFN bioassay was conducted using vesicular stomatitis Indiana
virus expressing GFP (VSIV-GFP). HeLa cells were transfected with
a plasmid expressing each of the nsp1 subunit gene, and then
stimulated with poly(I:C). The supernatants were collected, seri-
ally-diluted, and incubated with MARC-145 cells. After incubation,
cells were infected with VSIV-GFP. The presence of IFN in the
supernatant will inhibit the replication of VSIV-GFP, resulting in
the absence of GFP expression. If IFN suppression occurs by
arterivirus nsp1, a reduced amount of IFN secreted in the super-
natants will allow the replication of VSIV-GFP and so the GFP
expression will be visible. In the present study, two folds-dilution
of supernatant exhibiting the minimum 50% GFP expression was
calculated as the end point for IFN-directed inhibition of VSIV
replication. Cells transfected with the empty vector pXJ4 or pXJ41-
GST and stimulated with poly(I:C) resulted in efﬁcient production
of IFN in the supernatant, and the VSIV-GFP replication was
inhibited as anticipated. For this control, the end point for GFP
expression was determined as 1:16 (Fig. 5B, second and third
panels from top). Cells transfected with pXJ41 without stimulation
resulted in the absence of IFN production, and thus VSIV-GFP did
replicate normally and the end point was determined as 1 (Fig. 5B,
top panels). Cells incubated with the supernatant from nsp1
subunit-expressing cells showed a very little inhibition of VSIV-
GFP and the end point was determined to be 1:2 for each of the
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subunits. The inhibition level was 8-folds lower than that of the
control (1:16), indicating that each of nsp1 subunits strongly
suppressed the IFN production in transfected cells (Fig. 5B). These
observations were consistent with the luciferase assay data and
demonstrate the IFN suppression by arterivirus nsp1 subunits.
Phosphorylation and nuclear translocation of IRF3 in the presence
of nsp1 subunits
When stimulated for IFN induction, IRF3 is phosphorylated by
IKKε and/or TBK1 kinases, and the phosphorylated IRF3 results in
dimerization and conformational switch, exposing the nuclear
localization signal (NLS) for subsequent translocation to the
nucleus (Baccala et al., 2007). Some viral IFN antagonists degrade
IRF3, inhibit IRF3 phosphorylation, or block IRF3 nuclear translo-
cation (Ren et al., 2011; Sen et al., 2010; Zhu et al., 2011). Since our
results showed the IRF3-mediated IFN suppression by nsp1 sub-
units, and because for PRRSV, nsp1α- and nsp1β-mediated IFN
suppressions were IRF3-independent (Chen et al., 2010; Kim et al.,
2010), it was of interest to examine whether IRF3 function was
altered by nsp1 of other arteriviruses. The amounts of total IRF3
(Fig. 6A, middle panel) and phosphorylated IRF3 (pIRF3, Fig. 6A,
upper panel) were examined after expression of individual sub-
units of nsp1. No signiﬁcant changes were observed for levels of
IRF3 and pIRF3 in comparison to those of control, suggesting that
IRF3 inhibition occurred at steps after phosphorylation. We thus
explored the nuclear localization of IRF3 by cell fractionation
(Fig. 6B) and ﬂuorescence staining (Fig. 6C). After poly(I:C)
stimulation, IRF3 was partly accumulated in the nuclear fraction,
and this was not affected by expression of nsp1 subunits (Fig. 6B,
right upper panel). HSP90 and PARP as the cytosolic and nuclear
proteins markers, respectively, remained in their respective com-
partments (Fig. 6B, middle upper panel, lanes 1–9; middle lower
panel, lanes 10–18), indicating that the results were not due to the
cross-contamination during fractionation. To conﬁrm the cell
fractionation result, immunoﬂuorescence of endogenous IRF3
was conducted after poly(I:C) stimulation. Without stimulation,
IRF3 was distributed normally in the cytoplasm with some nuclear
diffusion (Fig. 6C, panel A), but when stimulated, it was translo-
cated to the nucleus (Fig. 6C, panel D). In cells expressing the nsp1
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Fig. 5. Suppression of IFN-β production by individual arterivirus nsp1 subunits. (A) HeLa cells were seeded in 12-well plates and co-transfected with pIFN-β-Luc, p4 IRF3–
Luc, or pRD II-Luc, along with individual arterivirus nsp1 genes and pTK-RL as an internal control at a ratio of 1:1:0.1. At 24 h post-transfection, cells were stimulated with
1 μg/ml of poly(I:C) for 12 h, and lysed for the reporter determination using the Dual Luciferase assay system (Promega). Relative luciferase activities were calculated by
normalizing the ﬁreﬂy luciferase to renilla luciferase activities according to the manufacturer's protocol. The data represent the means of three independent experiments,
each experiment in triplicate. Statistical signiﬁcance in fold changes of relative luciferase activity are indicated as follows: nPo0.05, and nnnPo0.01. (B) IFN bioassay using
vesicular stomatitis Indiana virus(VSIV)-GFP. HeLa cells in 6-well plates were transfected with individual arterivirus nsp1 subunit genes for 24 h, and stimulated with poly(I:
C) for 12 h. Cell culture supernatants were collected and diluted serially by 2-folds. MARC-145 cells were grown in 96-well plates and incubated with each dilution of
supernatants for 24 h, and then infected with VSIV-GFP at an MOI of 0.1 for 16 h. VSIV replication was measured by monitoring the ﬂuorescence by GFP expression.
M. Han et al. / Virology 458-459 (2014) 136–150 143
subunits (Fig. 6C, middle column, white arrows), IRF3 was found to
normally translocate to the nucleus after stimulation (Fig. 6C, left
column, white arrows). These results show that nsp1 did not affect
IRF3-nuclear translocation, suggesting that the nsp1-mediated IFN
suppression occurs downstream of IRF3 nuclear localization”
CBP degradation and nsp1 subunits
In our studies, all subunits of arterivirus nsp1 appear to
suppress the IFN production. Since CBP is degraded by PRRSV–
nsp1α in the nucleus (Han et al., 2013), we examined whether CBP
degradation was a common mechanism in arteriviruses. For this,
HeLa cells were transfected with plasmids expressing individual
nsp1 subunits, and the CBP degradation was determined by
immunoﬂuorescence and Western blot assays (Fig. 7). PRRSV–
nsp1α was used as a CBP degradation control and PRRSV–nsp1β
was used as a negative control. LDV–nsp1α caused a notable
reduction of CBP, and the level of reduction was comparable to
that of PRRSV–nsp1α (Fig. 7A, lanes 2, 4). In cells expressing LDV–
nsp1α and SHFV–nsp1γ, CBP degradation was also evident in
immunoﬂuorescence assay (Fig. 7B, panels M, c), even though
SHFV–nsp1γ-mediated CBP degradation was less evident in Wes-
tern blot. In contrast, no CBP degradation was observed for LDV–
nsp1β (panel Q), EAV–nsp1 (panel U), and SHFV–nsp1αβ (panel Y).
The CBP degradation was quantiﬁed by counting the numbers of
cells exhibiting the reduced CBP and the number of cells expres-
sing the respective nsp expression. Approximately 80% of cells
expressing PRRSV–nsp1α and 78% of cells expressing LDV–nsp1α
showed a signiﬁcant reduction of CBP whereas only approximately
30% of cells expressing SHFV–nsp1γ exhibited the CBP reduction
(Fig. 7C). Together with the data from Western blot, it further
conﬁrmed that LDV–nsp1α and SHFV–nsp1γ caused CBP degrada-
tion, resulting in the inhibition of enhanceosome formation and
thus suppression of IFN production.
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Fig. 6. Activation and nuclear localization of IRF3 in cells expressing the individual arterivirus nsp1 subunits. (A) Phosphorylation of IRF3 in the presence of arterivirus nsp1 subunits.
HeLa cells were transfected with plasmids expressing each of individual arterivirus nsp1 subunits for 24 h and stimulated by poly(I:C) for 8 h. Cells were lysed and subjected to
Western blot using phospho-IRF3 (Ser396) antibody (top panel), IRF3 antibody (second panel), and β-actin antibody (bottom panel). (B) Nuclear localization of IRF3 in cells expressing
the individual arterivirus nsp1 subunits. HeLa cells expressing individual nsp1 subunits were fractionated followed by Western blot using IRF3 antibody (upper panel), anti-HSP90
antibody as a cytosolic marker (second panel), anti-PARP antibody as a nuclear protein marker (third panel), and β-actin antibody as a loading control (bottom panel). (C) Nuclear
translocation of IRF3 in nsp1 subunit- gene transfected cells. Cells were stimulated with poly(I:C) for 8 h, ﬁxed with 4% paraformaldehyde, and incubated with rabbit anti-IRF3 Ab and
mouse anti-FLAG Ab, followed by incubation with Alexa Fluor 594-conjugated (red) and 488-conjugated (green) secondary antibodies, respectively, along with DAPI for nucleus
staining (blue). pXJ41 is an empty vector and used as a control. Arrows indicate IRF3 and respective nsp1 subunit in the nucleus.
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Fig. 7. Degradation of CBP by arterivirus nsp1 subunits. (A) HeLa cells were transfected with individual constructs expressing each of arterivirus nsp1 subunits for 24 h, and
cell lysates were subjected to Western blot using anti-CBP antibody to examine the endogenous level of CBP (top panel). The CBP degradation was quantiﬁed and relative
levels were shown below each lane. (B) Determination of CBP degradation by IFA. HeLa cells were grown to 40% conﬂuency and transfected with individual arterivirus nsp1
subunit constructs. At 24 h, cells were co-stained with rabbit anti-FLAG Ab and mouse anti-CBP Ab, followed by incubation with Alexa Fluor 594-conjugated (red) and 488-
conjugated (green) secondary antibodies, respectively, along with DAPI for nucleus staining (blue). Arrows indicate cells where CBP is degraded by nsp1. (C) The percentage
of cells showing signiﬁcant reduction of CBP was calculated using the following formula; (Number of cells showing more than 50% reduction of the CBP staining intensity
compared to the control CBP staining intensity out of 50 nsp1-expressing cells/(50 cells expressing each subunits of arterivirus nsp1)100.
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Suppression of ISRE by nsp1 subunits of arteriviruses
In addition to suppression of the IFN production pathway,
PRRSV–nsp1α and PRRSV–nsp1β have been shown to suppress
the JAK-STAT signaling pathway (Chen et al., 2010; Patel et al.,
2010). We thus further examined whether nsp1 subunits of other
arteriviruses would also suppress the IFN signaling. HeLa cells
were co-transfected with a plasmid expressing individual subunit
of arterivirus nsp1 and the ISRE-Luc reporter plasmid, followed by
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Fig. 8. Suppression of ISRE activities by arterivirus nsp1 subunits. (A) HeLa cells were co-transfected with 500 ng of pISRE-Luc, 500 ng of pXJ41 empty vector or a plasmid
expressing individual arterivirus nsp1 subunit along with pTK-RL as an internal control. At 24 h post- transfection, cells were incubated with 1000 units/ml of IFN-β for 12 h,
followed by luciferase reporter assays using the Dual Luciferase assay system (Promega). Relative luciferase activities were calculated by normalizing the ﬁreﬂy luciferase to
renilla luciferase activities. Statistical signiﬁcance in fold changes of relative luciferase activity between empty vector and each of the arterivirus nsp1 subunits is indicated as
follows: nPo0.05, and nnPo0.01. (B) HeLa cells were transfected with individual plasmids encoding nsp1 subunits for 24 h, followed by IFN treatment for 12 h. Cell lysates
were subjected to Western blot analyses using anti-PML antibody (top panel) and anti-ISG15 antibody (second panel). β-actin was used as a loading control (bottom panel).
(C) Reduced expression of PML in nsp1subunit-expressing cells. After IFN stimulation, cells were ﬁxed with 4% paraformaldehyde and incubated with rabbit anti-FLAG Ab
and mouse anti-CBP Ab for 2 h, followed by incubation with Alexa Fluor 594-conjugated (red) and Alexa Fluor 488-conjugated (green) secondary antibodies, respectively. The
nuclei were stained with DAPI (blue). Arrows indicate the reduction of PML expression. Fold changes of PML and ISG-15 levels were shown below each of the images,
respectively. (D) Percentage of cells showing reduced production of PML. Statistical signiﬁcance is indicated as follows: nnnPo0.01.
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stimulation with IFN-β. As shown in Fig. 8A, ISRE-dependent
luciferase expression was suppressed by each subunit of all
arteriviruses. To further conﬁrm their suppressive effects on IFN
stimulated gene (ISG) expression through the JAK-STAT pathway,
ISG15 and promyelocytic leukemia (PML), whose expression is
ISRE-dependent, were examined by Western blot (Fig. 8B; Chelbi-
Alix et al., 1995). The reduction of ISG15 (middle panel, lanes
3 through 9) and PML (upper panel, lanes 3 through 9) was
identiﬁed in cells expressing individual nsp1 subunit, in compar-
ison to those in mock-transfected cells. The suppression of ISG15
expression by SHFV nsp1 was relatively weaker than those of
PRRSV–nsp1β, LDV–nsp1β, and EAV–nsp1 but was still signiﬁcant.
The reduction of PML was also conﬁrmed by the staining of nsp1-
expressing cells (Fig. 8C). PML is a component of the nuclear
bodies (NBs) (Dyck et al., 1994), and thus is stained as a punctate
pattern in the nucleus. Compared to cells where no viral protein
was expressed, the reduction of PML-NBs was evident in cells
expressing PRRSV–nsp1α (panel G, arrow), PRRSV–nsp1β (panel J,
arrow), LDV–nsp1α (Panel M, arrow), LDV–nsp1β (Panel P, arrow),
EAV–nsp1 (panel S, arrow), SHFV–nsp1αβ (panel V, arrow), and
SHFV–nsp1γ (panels Y, arrow). The reduction of PML was quanti-
ﬁed by counting the number of cells exhibiting the reduced CBP
out of 200 cells expressing viral nsp1 (Fig. 8D). Approximately, 80%
of cells showed the reduction of PML-NBs for PRRSV–nsp1α,
PRRSV–nsp1β, LDV–nsp1α, and LDV–nsp1β, whereas 60% of cells
showed the reduction of PML-NBs for SHFV–nsp1αβ. In contrast,
only 40% of cells showed the reduction of PML for EAV–nsp1 and
SHFV–nsp1γ (Fig. 8D). Taken together, our results demonstrate
that each subunit of all arterivirus nsp1 contained the inhibitory
activity for ISRE and ISRE-dependent antiviral protein expression.
Discussion
During the processing of pp1a and pp1ab polyproteins in
arteriviruses, PLP1α/β-mediated proteolytic cleavages are unique
characteristics for nsp1 biogenesis, and the role of PLP1α/β for
polyproteins processing and viral genome replication has been
elucidated for PRRSV and EAV (For a review, see Fang and Snijder,
2010; Snijder et al., 2013). With an exception of SHFV, catalytic
sites for nsp1 of other arteriviruses have been either predicted or
conﬁrmed by experiments (den Boon et al., 1995; Snijder et al.,
1992). In the current study, we show that the processing of LDV–
nsp1 is similar to that of PRRSV–nsp1, while SHFV–PLP1α in
SHFV–nsp1 is non-functional as that of EAV–PLP1α. For EAV, the
displacement of C73 by K73 in nsp1 explains the functional
deﬁciency of PLP1α (Fig. 1A). For SHFV, two residues of C115 and
H130 are critical for the catalytic activity of PLP1α, and these
residues are conserved. However, a contiguous deletion of 55
amino acids is notable in the region between two catalytic
residues of C115 and H130 when compared to PRRSV (Fig. 1A),
thus likely contributing to the impaired function of SHFV–PLP1α.
To study the biogenesis of nsp1, the cleavage sites were ﬁrst
determined. The PRRSV–nsp1 cleavage site was initially predicted
to Q166↓R167 in the case of North American genotype PRRSV or
somewhere between Q166 and F173 for European genotype PRRSV
(Allende et al., 1999; den Boon et al., 1995). Recent studies
however, identiﬁed the cleavage at M180↓A181 for North Amer-
ican PRRSV, and similarly a corresponding site of H180↓S181 was
predicted as the cleavage site for European genotype PRRV
according to our sequence analysis (Chen et al., 2010; Sun et al.,
2009). The discovery of authentic cleavage site results in addition
of 14 amino acids to the C-terminus of PRRSV–nsp1α in contrast to
the initial prediction. A crystallographic study shows that these
additional 14 residues constitute the C-terminal extension (CTE) of
PRRSV–nsp1α and are essential for formation of the newly
described C-terminal zinc ﬁnger motif (Sun et al., 2009). We have
previously shown that these 14 residues are essential for the
nsp1α function for IFN suppression and cellular distribution (Song
et al., 2010). Hence, keeping the structural integrity of nsp1α
seems to be critical to retain its biological function for PRRSV
replication. Thus, among the PLP1α homologs in arteriviruses, only
PRRSV–PLP1α and LDV–PLP1α appear to be active and functional.
When compared the nsp1α–nsp1β junction sequence of LDV to
that of PRRSV, CPFxxAxAT(N)V (where x is any amino acid) is
conserved between the two viruses, and thus, nsp1α↓nsp1β
cleavage site for LDV–PLP1α is readily predictable. In fact, the
junction sequence is highly conserved among LDV, PRRSV, and
SHFV, and therefore, R181↓A182 is likely the correct cleavage site
for LDV–PLP1α, and G381↓Y382 for LDV–PLP1β. Similarly,
G350↓G351 is predicted to be the cleavage site for SHFV–PLP1β
(Fig. 1C). According to our mutational studies, the cleavage site for
SHFV–PLP1γ is reasonably predicted to Y479↓G480 rather than the
previous prediction of G480↓R481.
It is intriguing that all subunits of arterivirus nsp1 have the ability
to suppress the type I IFN production despite the limited sequence
similarities. However, some critical functional motifs appeared to be
conserved. The results from luciferase reporter assays indicate that
either the IRF3-mediated or NF-κB-mediated signaling pathway are
inhibited. In the current study, no changes were identiﬁed for both
phosphorylation and nuclear localization of IRF3 in cells expressing
arterivirus nsp1 subunits, which is in agreement with a previous
study by Chen et al. (2010). Thus, it is proposed that the IFN
inhibition by arterivirus nsp1 subunits may be a nuclear event. All
subunits of arterivirus nsp1 are found to localize in the nucleus, but
their role in the nucleus seems variable. PRRSV–nsp1α degrades CBP
which is a crucial co-factor for IFN-β transcription (Han et al., 2013),
and CBP degradation is also observed for LDV–nsp1α (Fig. 7). The
subcellular distribution of PRRSV–nsp1α and LDV–nsp1α are both
nuclear–cytoplasmic, and their distribution patterns are similar
(Fig. 4). Since the PRRSV–nsp1α-mediated CBP degradation is a
nuclear event and proteasome-dependent and also because of the
lack of direct binding of PRRSV–nsp1α to CBP (Kim et al., 2010), the
nuclear form of PRRSV–nsp1α is likely responsible for CBP degrada-
tion through utilizing a mediator or other signaling pathway to
complete the degradation process.
In contrast to the nuclear–cytoplasmic distribution of nsp1α,
PRRSV–nsp1β, LDV–nsp1β, and EAV–nsp1 are predominantly
nuclear without cytoplasmic distribution (Table 3). IFN synthesis
is inhibited by these proteins but a notable CBP degradation is
absent, suggesting a novel strategy by nsp1β for IFN suppression.
For SHFV–nsp1γ, CBP degradation was less pronounced but
apparent by immunoﬂuorescence in some SHFV–nsp1γ expressing
cells, suggesting that a certain form of nsp1γ is probably respon-
sible for CBP degradation. In addition to suppression of the IFN
production pathway, all subunits of arterivirus nsp1 are found to
inhibit the JAK-STAT signaling pathway. The basis for ISRE inhibi-
tion by LDV–nsp1α is similar to that of PRRSV–nsp1α as for CBP
degradation. For PRRSV–nsp1β, the KPNA1 degradation has been
reported to cause the inhibition of ISGF3 nuclear translocation
thus to result in the inhibition of JAT-STAT pathway. Whether
LDV–nsp1β and EAV–nsp1 also block the ISGF3 nuclear transloca-
tion remain to be determined. Different types of subcellular
distribution are found for SHFV–nsp1αβ and SHFV–nsp1γ, sug-
gesting that their nuclear localization is crucial for IFN suppres-
sion. The molecular basis for IFN suppression by SHFV–nsp1αβ
and SHFV–nsp1γ needs to be further explored.
In summary, we have shown that the nsp1 subunits of all four
arteriviruses are able to modulate the IFN production either
through the production pathway or the signaling pathway, and
their biological function seems to be corresponding to their
cellular distributions. Taking together, nsp1 subunits of all viruses
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in the family Arteriviridae are important IFN antagonists, and their
IFN modulatory function seems to be a common strategy for
evading the host immune system.
Materials and methods
Cells and viruses
HeLa cells (NIH AIDS Research and Reference Reagent Program,
Germantown, MD) and MARC-145 cells (Kim et al., 1993) were grown
in minimum essential medium (MEM) and Dulbecco's modiﬁed
Eagle's medium (DMEM; Mediatech Inc., Manassas,VA), respectively,
supplemented with 10% heat-inactivated fetal bovine serum (FBS;
HyClone, Logan, UT) in a humidiﬁed incubator with 5% CO2 at 37 1C.
The PA8 strain of the North American genotype PRRSV (Wootton et al.,
2000) was used. The full-length genomic sequence of PA8 shares
99.2% identity with the prototype PRRSV VR2332 of the North
American genotype (Nelsen et al., 1999). Vesicular stomatitis virus
(Indiana strain) expressing green ﬂuorescent protein (VSV-GFP; Dalton
and Rose, 2001) was kindly provided by Adolfo Garcίa-Sastre (Mt.
Sinai School of Medicine, New York, NY). LDV was provided by Steve
Jennings (Charles River Laboratories, Wilmington, MA). This virus was
isolated from a mice breeding colony and designated LDV-Urbana. The
SHFV nsp1 gene was cloned from the cDNA library provided by Eric
Snijder (Leiden University Medical Center, Leiden, Netherlands). The
nsp1 sequence from SHFV cDNA shared 99.2% nucleotide and 98.3%
amino acid identity with the nsp1 sequence from GenBank (accession
no.: NC_003092).The EAV nsp1 gene was cloned from the Bucyrus
strain of EAV.
Antibodies and chemicals
Polyinosinic:polycytidylic [poly (I:C)], DAPI (40,6-diamidino-2-
phenylindol), anti-Flag MAb (F3165), and anti-FLAG PAb (F7425)
were purchased from Sigma (St. Louis, MO). Anti-β-actin MAb (sc-
47778), anti-CBP MAb (sc-7300), anti-IRF3 PAb (sc-9082), anti-
HSP90 MAb (sc-69703), anti-PARP PAb (sc-7150) and anti-PML PAb
(sc-5621) were purchased from Santa Cruz Biotechnologies Inc.
(Santa Cruz, CA). Anti-ISG15 PAb was purchased from Thermo
Scientiﬁc Pierce (Rockford, IL). Phospho-IRF-3 (Ser396) mAb was
purchased from Cell Signaling (Danvers, MA). The peroxidase-
conjugated Afﬁnipure goat anti-mouse IgG and peroxidase-
conjugated Afﬁnipure goat anti-rabbit IgG were purchased from
Jackson Immuno Research (West Grove, PA). Alexa-Flour 488-
conjugated and Alexa-Flour 594-conjugated secondary antibodies
were purchased from Invitrogen (Carlsbad, CA).
Plasmids and DNA cloning
The plasmids pFLAG-nsp1, pFLAG-nsp1α and pFLAG-nsp1β
contain the full-length nsp1, nsp1α, and nsp1β genes of PRRSV,
respectively, fused with an N-terminal FLAG tag (Han et al., 2013;
Song et al., 2010). The full sequence of LDV nsp1, EAV nsp1, SHFV
nsp1, and their subunits including the N- or C-terminal FLAG tag
were ampliﬁed by PCR using cDNA clones of LDV, EAV, and SHFV
using primer sets listed in Table 1. The SHFV–nsp1 gene was kindly
provided by Eric Snijder (Leiden University Medical Center, Leiden,
Netherlands). The PCR fragments were cloned into the pXJ41
mammalian expression vector using the indicated restriction
enzymes (Xiao et al., 1991). Mutant genes were generated by
PCR-based site-directed mutagenesis using primers listed in
Table 1
Oligonucleotides used for cloning nsp1 genes and their sequences.
Oligonucleotides Primer sequence
LDV-F-nsp1α-Fwd 50-GCCGAATTCCACCATGGATTACAAGGATGACGACGATAAGATGCAGTCGGGATTCG-30
LDV-F-nsp1α-Rev 50-GCCCTCGAGCTATCGTGCATCAGCAAAAGGACAT-30
LDV-F-nsp1β-Fwd 50-GCCGGATCCACCATGGATTACAAGGATGACGACGATAAGGCGAATGTGTGGCGTTAC-30
LDV-F-nsp1β-Rev 50-GCCGGTACCCTACCCATAGTATTTTCTAGTTTGGAATCTA-30
EAV-F-nsp1-Fwd 50-GCCGAATTCACCATGGATTACAAGGATGACGACGATAAGATGGCAACCTTCTCCGC-30
EAV-F-nsp1-Rev 50-GCCCTCGAGCTAGCCGTAGTTGCCAGCAGGC-30
SHFV-F-nsp1α-Fwd 50-GCCGAATTCACCATGGATTACAAGGATGACGACGATAAGTTCTGTGAGTGCCC-3’
SHFV-F-nsp1α-Rev 50-GCCCTCGAGCTATGCATGCCACTCGACATGATCTATG-30
SHFV-F-nsp1β- Fwd 50-GCCGAATTCACCATGGATTACAAGGATGACGACGATAAGGGTGTTAAGCCTGG-30
SHFV-F-nsp1β-Rev 50-GCCCTCGAGCTAACCGAAATAAGTCTTCCC-30
SHFV–nsp1β-F-Rev 50–GCCCTCGAGCTACTTATCGTCGTCATCCTTGTAATCACCGAAATAAGTCTTCCC-30
SHFV-F-nsp1γ- Fwd 50–GCCGAATTCACCATGGATTACAAGGATGACGACGATAAGGGAAATGCCAGTTCGG-30
SHFV-F-nsp1γ-Rev 50–GCCCTCGAGCTAGTAACGCGTTCCGAATCC-30
SHFV-F-nsp1γ/2 P-Rev 5'-GCCCTCGAGCTAGTCTGTAGTGACTTTGG-30
Restriction enzyme recognition sequences are underlined. The FLAG tag is italicized and underlined.
Table 2
Mutagenic oligonucleotides and their sequences.
Oligonucleotides Primer sequence
SC246A-Fwd 50-CTTTGAGCATGGCCGCGCCTGGCTGAAGTTGTTC-30
SC246A-Rev 50-GAACAACTTCAGCCAGGCGCGGCCATGCTCAAAG-30
SH309A-Fwd 50-ATCTTGGCTCGGGGCCATCGGTCATGCCG-30
SH309A-Rev 50-CGGCATGACCGATGGCCCCGAGCCAAGATC-30
SC378A-Fwd 50-CCCTCACTGCTGGGTTCGCTTGGTTGCAGCTATTTC-30
SC378A-Rev 50-GAAATAGCTGCAACCAAGCGAACCCAGCAGTGAGGG-30
SH433A-Fwd 50-CTAGTGATTCTTCCATCAGAGCCATTTCTCCCGTCCCTATAC-
30
SH433A-Fwd 50-GTATAGGGACGGGAGAAATGGCTCTGATGGAAGAAT
CACTAG-30
SG164S-Fwd 50-CAGGGAAGACTTATTTCAGTGGAAATGCCAGTTCG-30
SG164S-Rev 50-CGAACTGGCATTTCCACTGAAATAAGTCTTCCCTG-30
SG164V-Fwd 50-AGGGAAGACTTATTTCGTTGGAAATGCCAGTTCGG-30
SG164V-Rev 50-CCGAACTGGCATTTCCAACGAAATAAGTCTTCCCT-30
SG165S-Fwd 50-AGGGAAGACTTATTTCGGTAGCAATGCCAGTTCGGT
TAGCT-30
SG165S-Rev 50-AGCTAACCGAACTGGCATTGCTACCGAAATAAGTCTTCCCT-
30
SG165V-Fwd 50-GGAAGACTTATTTCGGTGTAAATGCCAGTTCGGTTAG-30
SG165V-Rev 50-CTAACCGAACTGGCATTTACACCGAAATAAGTCTTCC-30
SG294S-Fwd 50-GGAACGCGTTACAGTCGCCGTCGGG-30
SG294S-Rev 50-CCCGACGGCGACTGTAACGCGTTCC-30
SG294V-Fwd 50-GAACGCGTTACGTTCGCCGTCGGGG-30
SG294V-Rev 50-CCCCGACGGCGAACGTAACGCGTTC-30
SY293S-Fwd 50-CGATTTAGGATTCGGAACGCGTAGCGGTCGCCGTCG-30
SY293S-Rev 50-CGACGGCGACCGCTACGCGTTCCGAATCCTAAATCG-30
SY293V-Fwd 50-CGATTTAGGATTCGGAACGCGTGTCGGTCGCCGTCG-30
SY293V-Rev 50-CGACGGCGACCGACACGCGTTCCGAATCCTAAATCG-30
SR295S-Fwd 50-TCGGAACGCGTTACGGTAGCCGTCGGG-30
SR295S-Rev 50-CCCGACGGCTACCGTAACGCGTTCCGA-30
SR295V-Fwd 50-TCGGAACGCGTTACGGTGTCCGTCGGGG-30
SR295V-Rev 50-CCCCGACGGACACCGTAACGCGTTCCGA-30
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Table 2. Reporter plasmids, pIFN-β-Luc and p4xIRF3-Luc were
kindly provided by Stephan Ludwig (Ehrhardt et al., 2004; Insti-
tute of Molecular Medicine, Heinrich Heine Universtät, Düsseldorf,
Germany), and used for luciferase assays. The p4xIRF3-Luc con-
struct contains four copies of the IRF3-speciﬁc PRDI/III domain
of the IFN-β promoter in front of the luciferase reporter gene.
The plasmid pPRDII-Luc contains two copies of the NF-κB-speciﬁc
PRDII binding region of the IFN-β promoter in front of the
luciferase gene and was kindly provided by Stanley Perlman
(University of Iowa, IA; Zhou and Perlman, 2007). The plasmid
pISRE-Luc contains the IFN stimulated response element (ISRE)
binding sequence and was purchased from Stratagene (La Jolla,
CA). The Renilla luciferase plasmid pRL-TK contains the herpes
simplex virus thymidine kinase (HSV-tk) promoter and was
included to serve as an internal control in luciferase reporter
assay (Promega).
DNA transfection and protein expression
DNA transfection was performed in HeLa or MARC-145 cells
using Lipofectamine 2000 according to the manufacturer's instruc-
tions (Invitrogen; Carlsbad, CA). HeLa or MARC-145 cells were
seeded in 6-well plates a day prior to transfection and grown to
80% conﬂuency. A transfection mix containing DNA and Lipofecta-
mine 2000 in OPTI-MEMs I (Invitrogen; Carlsbad, CA) was
incubated at room temperature (R/T) for 20 min and added to
each well. After incubation, the transfection mix was replaced
with a fresh medium, and cells were incubated for 24 h to allow
gene expression.
Western blot analysis
Cells were lysed in lysis buffer (20 mM Tris [pH 7.5], 150 mM
NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100, 1% NP-40)
supplemented with a cocktail of protease inhibitors (P-8340
Sigma). Cell lysates were centrifuged and supernatants were
resolved by 7.5%, 10%, or 12% SDS-PAGE, followed by transfer to
Immobilon-P membrane (Millipore). After blocking with 5% skim
milk powder in TBS-T (10 mM Tris–HCl [pH 8.0], 150 mM NaCl, 1%
Tween 20), membranes were incubated with primary antibody
dissolved in TBS-T containing 5% skim milk powder for 1 h at R/T
followed by washing and incubation with horseradish peroxidase-
conjugated secondary antibody for 1 h at R/T. After three washes
with TBS-T, proteins were visualized using the Enhanced Chemi-
luminescence system (Pierce, Rockford, IL). Digital signal acquisi-
tion and analysis were conducted using GraphPad Prism 5.0
(GraphPad).
Immunoﬂuorescence analysis (IFA)
Cells were seeded on cover slips and transfected with indivi-
dual plasmids for 24 h. After washing with phosphate-buffered
saline (PBS), cells were ﬁxed with 4% paraformaldehyde for 10 min
at R/T in (PBS), and then permeabilized using 0.1% Triton X-100 for
10 min at R/T. After blocking with 1% BSA in PBS for 30 min, cells
were incubated with primary antibody in PBS containing 1% BSA
for 2 h followed by incubation with Alexa Fluor 488- and/or Alexa
Fluor 594-conjugated secondary antibody for 1 h. Nuclear staining
was performed with DAPI for 3 min at R/T. After washing with PBS,
coverslips were mounted onto microscope slides using Fluoro-
mount-G mounting medium (Southern Biotech, Birmingham, AL),
and examined under a ﬂuorescence microscope (Leitz Laborlux
12). To quantify degradation of CBP and reduction of PML, the
formula described previously (Han et al., 2013) were used to
calculate the percentage of cells with visible reduction of CBP or
PML-NB.
Luciferase reporter assay
HeLa cells were grown to a density of 5104 cells/well in 12-well
plates and transfected with various combination of plasmid DNA:
0.5 μg of plasmid encoding the subunit protein of nsp1, 0.5 μg of pIFN-
β-Luc, pPRDII-Luc, p4xIRF3-Luc, or pISRE-Luc, and 0.05 μg of pLR-TK
were co-transfected using Lipofectamine. At 24 h post-transfection,
cells were stimualted with 0.5 μg of poly (I:C) for 16 h and cell lysates
were prepared for luciferase assays. For pISRE-Luc, cells were incu-
bated with 1000 units of human IFN (bioWORLD, Dublin, OH) for 16 h.
Luciferase activities were measured using the Dual-Glo Luciferase
assay system according to the manufacturer's instructions (Promega).
Values for each sample were normalized using Renilla luciferase
activities and the results were expressed as relative luciferase activ-
ities. All assays were repeated at least three times, and each sample
was analyzed in triplicates.
VSIV-GFP bioassay
HeLa cells in 6-well plates were transfected with 2 μg of
plasmids expressing individual subunit of arterivirus nsp1. At
24 h post-transfection, cells were stimulated with 1 μg of poly (I:
C) by transfection and continued incubation for 12 h. Supernatant
was harvested and serially diluted by 2-folds. MARC-145 cells
were grown in 96-well plates and incubated for 24 h with 100 μl
of each dilution of the supernatant. Cells were then infected with
100 μl of VSIV-GFP of 104 PFU/ml and incubated for 16 h. Cells
were ﬁxed with 4% paraformaldehyde, and GFP expression was
examined under an inverted ﬂuorescence microscopy (Nikon
Eclipse TS100).
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